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Abstract
Major knowledge gaps limit the development and implementation of interventions to improve employment outcomes
among people with cancer. To identify research priorities to improve employment outcomes after cancer, the National
Cancer Institute sponsored the meeting “Evidence-Based Approaches for Optimizing Employment Outcomes among Cancer
Survivors.” This article describes research recommendations stemming from the meeting. At the patient level, longitudinal
studies are needed to better understand how patient sociodemographic and clinical characteristics and their experiences at
work shape employment outcomes. Interventions that mitigate the impact of cancer and its treatment on employment are
critical. At the provider-level, future research is needed to characterize the extent to which physicians and other healthcare
providers talk to their patients about employment concerns and how that information is used to inform care. Additionally,
there is a need to test models of care delivery that support routine screening of employment concerns, the capture of employ-
ment outcomes in electronic health records, and the effective use of this information to improve care. At the employer level,
evidence-based training programs are needed to prepare supervisors, managers, human resources staff, and occupational
health professionals to address health issues in the workplace; and future interventions are needed to improve patient –
employer communication and facilitate workplace accommodations. Importantly, research is needed that reflects the per-
spectives and priorities of patients and their families, providers and healthcare systems, and employers. Transdisciplinary
partnerships and stakeholder engagement are essential to ensure that employment-focused interventions and policies are
developed, implemented, and sustained in real-world healthcare delivery and workplace settings.
Cancer and its treatment frequently lead to symptoms that in-
terfere with the ability to work, placing cancer survivors and
their families at risk for financial hardship and psychosocial
distress (1–6). Common side effects such as fatigue, lymph-
edema, and cognitive limitations can lead to poor work out-
comes, such as prolonged sick leave, schedule and role changes,
and job loss (7–12). Additionally, the time demands associated
with cancer treatment may also make it difficult to sustain em-
ployment, forcing some survivors to work less, take a leave of
absence, or withdraw from the labor force entirely (13–15).
Approximately two-thirds of people diagnosed with cancer
return to work at some point after diagnosis (7). However, work
outcomes vary widely by disease and treatment, sociodemo-
graphic, and workplace characteristics. Survivors diagnosed
with advanced disease and who receive intensive treatment are
more likely to take extended sick leave, report loss of productiv-
ity if they remain at work, and non employment if they are no
longer able to work. For adolescent and young adult (AYA) can-
cer survivors, cancer can be particularly disruptive because their
diagnosis often coincides with entering or preparing for the
work force (16,17). Additionally, survivors with lower socioeco-
nomic status, racial and ethnic minority survivors, survivors
employed in demanding jobs, and those who lack accommodat-
ing employers are more likely to report poor work outcomes
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(7,18–21). It is also widely accepted that a survivor’s job perfor-
mance, satisfaction, and engagement prior to cancer diagnosis
are important drivers of work outcomes after cancer (22).
However, few studies have examined these relationships and
their impact on employment and job performance.
Minimizing work-related consequences is not generally a fo-
cus of cancer treatment, and few interventions exist to help
people with cancer maintain their engagement and precancer
job performance at work. Major knowledge gaps limit the ability
to develop and implement interventions to improve cancer-
related employment outcomes. Among populations where em-
ployment outcomes are not well documented, descriptive work
is needed to better understand the scope and predictors of dif-
ferent employment outcomes. Among populations where em-
ployment outcomes are better understood, research is needed
to identify effective interventions and to implement those inter-
ventions into practice.
In response to persistent gaps in the literature, the National
Cancer Institute’s Division of Cancer Control and Population
Sciences convened a 1.5-day meeting to develop a research
agenda focused on optimizing work outcomes among cancer
survivors. A select group of 29 oncologists, occupational thera-
pists, rehabilitation practitioners, employment representatives,
researchers, and research funders were convened for the meet-
ing, “Evidence-Based Approaches for Optimizing Employment
Outcomes among Cancer Survivors,” held August 11–12, 2016, to
examine the problem of cancer-related work limitations from
multiple perspectives. For the purposes of the discussion, cancer
survivors were defined as anyone who had been diagnosed with
cancer, including individuals who were currently receiving treat-
ment. Work outcomes included returning to work (RTW) as well
as job retention (ie, working during treatment and recovery), ab-
senteeism, presenteeism (ie, functional limitations interfering
with productivity), opportunities for promotion and advance-
ment, and job satisfaction. Additional information about the
meeting and the participants can be found at: https://healthcare-
delivery.cancer.gov/employment/approaches.html. This article
describes the research needs identified from the meeting, which
have been further elaborated through subsequent discussions
among meeting participants and collaborators.
Patient-Level Research Gaps and
Recommendations (Box 1)
Gap 1: There are limited data about the unique effect of cancer
and its treatment on employment and the mechanisms through
which cancer impacts different work outcomes over time.
Most studies of cancer-related work limitations have been
cross-sectional assessments of patients at different points in
their treatment (10,13,15,23). Although informative, these stud-
ies likely underestimate the magnitude of work limitations. As
suggested by a few longitudinal studies, the impact of cancer on
employment may be greatest in the period immediately follow-
ing diagnosis, and the likelihood of being employed and the im-
pact of cancer on work ability, hours worked, and income is
inversely associated with time since diagnosis and treatment
(24–26). However, cancer’s impact on employment can persist
years after the end of treatment, becoming cumulative and
long-lasting (27). Furthermore, the trajectory of work limitations
may change with the expanded use of targeted therapies, which
can have different side-effect profiles than nontargeted thera-
pies and are frequently given over a long period of time (28,29).
Caregivers of cancer survivors also frequently take leave from
work and have decreased productivity because of their caretak-
ing responsibilities (30–34).
Future research should build upon the findings of previous
studies to better understand work limitations experienced by
cancer survivors and their caregivers, and to gather the data
necessary to develop and evaluate interventions to improve
RTW, job retention, and other employment outcomes. Self-
reported employment outcomes and experiences should be in-
cluded in cohort studies of adult and AYA cancer survivors to
understand how patient sociodemographic characteristics,
behaviors, cancer type, treatment, and toxicities affect different
employment outcomes. Additionally, employment-focused lon-
gitudinal studies are needed that begin prior to cancer treat-
ment and continue posttreatment and assess patterns of
employment and modifiable predictors of employment out-
comes. Detailed data should be collected about cancer survi-
vors’ disease, treatment and sociodemographic characteristics
as well as their industry, occupation, and job demands.
Additionally, data should be collected about modifiable predic-
tors of employment outcomes at the level of providers and
healthcare systems and employers to inform future interven-
tions. It will be especially important to capture the experiences
of survivors who may be at high risk for poor employment out-
comes such as survivors diagnosed with advanced disease and
who experience treatment toxicities that limit functioning as
well as survivors who are self-employed, temporary and con-
tract workers, and those employed in positions without paid
sick leave or options for flexible scheduling or remote work.
Furthermore, future research should characterize disparities in
work outcomes by race and ethnicity, socioeconomic status,
and other patient characteristics to identify possible modifiable
targets for intervention.
Gap 2: Interventions are needed to address cancer-related
work limitations and concerns throughout cancer treatment
and recovery.
For cancer survivors who are motivated to work, interven-
tions are needed to support a timely RTW, job retention, and
Box 1. Research recommendations to improve patient-level as-
sessment of cancer-related work outcomes and implementation
of effective interventions
1. Employment outcomes should be included in cohort studies of
cancer survivors to characterize how patient sociodemographic
characteristics, behaviors, cancer type, treatment, and toxicities af-
fect cancer-related work outcomes.
2. Longitudinal studies should evaluate facilitators and barriers
to employment over time and identify modifiable risk factors
for different employment outcomes. Studies should recruit di-
verse clinical and sociodemographic samples and capture the
experiences of survivors who may be at high risk for poor em-
ployment outcomes.
3. Future studies should test multidisciplinary rehabilitation
interventions in the United States using larger samples and ex-
perimental designs as well as identify other interventions that
mitigate the impact of cancer and its treatment on employ-
ment outcomes.
4. Strategies should be tested to help cancer survivors and their
families understand their legal rights pertaining to leave, job
protection, and insurance coverage and to facilitate their access
to state, municipal, and community-level programs and policies
that are relevant for their needs.
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work ability. Depending on the individual, a range of interven-
tions may be needed to successfully conavigate cancer treatment
and work. Over the last 30 years, a few interventions have been
developed and tested to improve cancer-related employment out-
comes, ranging from psychoeducation, physical training, rehabili-
tation and symptom management, and communication skills
programs to help patients talk to their employers (35–39). Results
from these studies are mixed and suggest that multidisciplinary
rehabilitation programs, typically comprising a combination of
functional restoration, physical training, psychosocial support,
and patient education, are associated with improved work out-
comes (37), a finding that aligns with the complex nature of
cancer-related work limitations (40). There is also some evidence
that targeted education coupled with group discussion and high-
intensity physical activity improve work outcomes (41,42).
Most of the existing evidence base is limited by small samples
and interventions that were tested using single group or non-
experimental designs. Furthermore, much of the intervention re-
search, particularly studies of multidisciplinary rehabilitation,
have occurred in European countries that have different labor
market, healthcare, and health insurance systems than the
United States; therefore, it is unclear how well results from these
studies will generalize. However, the risk of nonemployment
among cancer survivors is similar between the US and Europe
(43). Thus, future studies should build on previous international
studies to conduct multidisciplinary rehabilitation interventions
in the US, using larger samples and experimental designs. In fact,
cancer rehabilitation, a multidisciplinary suite of interventions
designed to address the physical, psychosocial, and cognitive se-
quelae of cancer and its treatment has been recommended in the
US as a strategy to improve survivors’ ability to work (44).
Research is needed to build the evidence base about the effective-
ness of cancer rehabilitation for employment outcomes as well
as expand upon past studies to identify other interventions that
mitigate the impact of cancer and its treatment on employment.
Because employment outcomes are influenced by factors at
the level of patients, provider/healthcare systems, and
employers—as well as broader municipal, state, and federal pol-
icies, a multilevel approach to improving employment out-
comes is warranted. At the patient level, research is needed to
ensure that all survivors have the knowledge and skills to ac-
cess federal, state, and local resources that already exist.
Although a great deal of information about minimizing risks to
employment is available, this information is often not centrally
located, well organized, or effectively communicated. To that
end, research is needed to identify the best approaches to help
cancer survivors and their families understand and access the
legal protections afforded by the Americans with Disability Act
and the Family Medical Leave Act as well as resources offered
by state and municipal-level programs and policies, the Job
Accommodations Network (45), community organizations such
as Cancer and Careers (46), and resources within the healthcare
system. Research and intervention needs at the level of health-
care providers and delivery systems and employers are dis-
cussed in the next two sections.
Healthcare Providers and Delivery System
Level Gaps and Research Recommendations
(Box 2)
Gap 1: The extent to which healthcare providers address em-
ployment limitations and concerns and the impact on work out-
comes is poorly understood.
The National Academy of Medicine report, “From Cancer
Patient to Cancer Survivor: Lost in Transition,” recommends
that employers, healthcare providers, and other stakeholders
work to minimize the adverse effects of cancer on employment
and support survivors who experience limitations in their abil-
ity to work (47). Furthermore, the American College of Surgeons
Commission on Cancer mandates that accredited programs of-
fer survivorship care plans, which may foster patient –provider
communication about employment concerns and facilitate
referrals to appropriate services (48). Healthcare providers—
including oncologists, primary care providers, nurses, social
workers, rehabilitation specialists, and occupational
therapists—can be an important source of information and sup-
port for individuals who are navigating the intersection be-
tween cancer and work (49). However, despite evidence
suggesting that survivors would like to receive support and in-
formation about returning to work, working during treatment,
and other related issues, survivors generally receive little guid-
ance about employment from their healthcare providers (50–
53), and vocational counseling is rarely part of survivorship care
planning (54). Confusion over which member of the healthcare
team is responsible for addressing employment may serve as a
barrier to addressing these issues as part of care delivery. There
may also be differences by discipline in how providers view
their role in addressing employment issues and concerns (22).
Future research should characterize the extent to which
healthcare providers talk to their patients about their job, goals
for working during treatment, and how cancer treatment may
interfere with the ability to work. In particular, research is
needed to better understand the frequency and content of these
conversations, and which member(s) of the healthcare team are
involved as well as whether the communication was effective in
helping patients understand the implications of their cancer and
treatment for work. Research is needed to understand how infor-
mation about a person’s job and work-related concerns are used
to inform treatment decisions when multiple treatment options
are available. Additionally, improving care coordination, such as
scheduling treatment to minimize work disruption and facilitat-
ing referrals to rehabilitation, social work, or other services are
also important areas for future research. Subsequently, research
is needed to build upon this information to develop and
Box 2. Research recommendations to improve the provider-
and health system-level assessment of cancer-related work
outcomes and implementation of effective interventions
1. Future research should characterize the extent to which
healthcare providers talk to their patients about employment
as well as the content of these conversations and the impact of
these conversations on treatment decisions, care coordination,
and work outcomes.
2. Patients should be systematically screened for work limita-
tions and concerns throughout the course of treatment in a
manner that aligns with clinic staffing and workflow and effec-
tively informs care, triggers referral to rehabilitation, social
work, and other services.
3. Information about employment should be assessed as part of
clinical trials and routine clinical practice and captured in the
electronic health record (EHR) to understand how specific treat-
ments or doses of a given treatment impact work outcomes.
These data can be used to inform the care of individual
patients as well as facilitate research.
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implement models of care that foster routine screening for
patients’ employment concerns, including clarifying and institu-
tionalizing appropriate referral patterns into the clinic workflow.
Much of what we know about the practices of healthcare pro-
viders in the context of cancer and employment has been
reported from the patient’s perspective. Future studies have the
opportunity to build on this research to capture the perspective of
both providers as well as the systems in which care is delivered.
A systematic investigation is needed of the interpersonal and in-
stitutional situations that foster the initiation of discussions
about workplace issues and what resources oncologists, nurses,
and other providers need to address employment issues with
their patients. This information is critical to ensure that efforts to
integrate interventions addressing cancer-related work limita-
tions into care are responsive to perspectives of providers, clinical
work flow, and other constraints within the healthcare system.
Gap 2: Cancer survivors are not systematically screened for
employment concerns from diagnosis forward, and information
about employment is not typically used to guide cancer care
delivery.
Although a patient’s employment status is typically captured
during the initial intake visit, the nature of their job, schedule,
and access to paid leave are not. Therefore, research is needed to
develop a brief screen for work-related limitations and concerns.
Effectively screening patients for work-related limitations and
concerns can solicit input from patients and their families about
their goals for work; initiate discussions about the potential im-
pact of cancer treatment on their work lives; and identify survi-
vors at risk for poor work outcomes. This recommendation is
akin to ongoing efforts to screen cancer patients for distress (48)
and to capture patient-reported symptom data at the point of
care (55), activities pursued with the goal of identifying patients
who are in need of additional support or intervention. The per-
son or professions best prepared to provide screening will vary
by healthcare delivery setting. However, examples of staff who
may fill this role include nurses, nursing assistants, patient navi-
gators, and social workers.
Consistent with the goals of rapid-learning systems for
healthcare, information about employment should also be cap-
tured in electronic health records (EHR) to build a repository of
data about how specific treatments or doses of a given treat-
ment might impact patients’ work ability and the association
between symptom prevalence and severity and work outcomes.
This information can inform patient care and identify clinical,
rehabilitation, supportive care, and other healthcare interven-
tions that minimize the impact of cancer on employment (56).
Likewise, employment outcomes should be captured in the con-
text of clinical trials to assess the impact of novel therapeutics
on different work outcomes. As with other rapid-learning sys-
tems in oncology, the collection and use of patient data in the
context of employment must be done in accordance with the
Health Insurance Portability and Accountability Act (HIPAA)
(57). Additionally, complementary efforts to inform and educate
patients about how their data are used will help to build under-
standing and trust in this new era of healthcare delivery (58).
Employer-Level Gaps and Research
Recommendations (Box 3)
Gap 1: The employer perspective is lacking from research on
cancer-related work limitations.
Employers are uniquely knowledgeable about how specific
employment situations can be modified in response to a cancer
diagnosis, and in some cases, will have workplace-level policies
governing paid sick leave, remote work, and other accommoda-
tions for employees with health problems. Although the work
environment largely influences the extent to which cancer will
lead to poor employment outcomes, the perspectives and expe-
riences of employers are missing from the scientific literature.
Further, the extent to which work outcomes differ by industry/
occupation, employer size, benefits, and other workplace fea-
tures is unknown. The few studies of employer perspectives
have been conducted outside the US. These studies suggest that
employers are often uncertain about the best way to manage an
employee with cancer. However, clear communication, support,
and return to work policies can all be helpful in supporting an
employee with cancer (59). Given the protracted nature of can-
cer treatment, there are multiple events that need to be navi-
gated related to initial disclosure, employment changes during
treatment, and planning for work posttreatment (60). When
employers are absent from research, individual studies may fail
to account for “real-world” considerations involved in managing
employees with cancer and chronic health problems. Likewise,
researchers may be less likely to collect data that is meaningful
and actionable for employers, thereby limiting the utility of the
findings.
Partnerships between researchers and individual employers
or employer associations are needed to engender bidirectional
sharing of information and expertise to optimize work out-
comes among cancer survivors. Additionally, these partner-
ships could stimulate research on tangible benefits to
employers, such as retaining valuable employees and saving on
the cost of retraining new staff (61). To this end, researchers are
encouraged to include employers or employer representatives
on the external advisory panels for their studies, along with
patients and providers, to ensure that relevant data are col-
lected and that findings are disseminated to workplace policy-
makers. Relatedly, studies designed to understand the
employer perspective on the challenges of managing employees
with health problems and best practices for supporting these
Box 3. Research recommendations to improve the employer-
level assessment of cancer-related work outcomes and imple-
mentation of effective interventions
1. Research on cancer-related work outcomes should be
grounded in an understanding of employers’ experiences and
resources for managing employees with cancer or other health
problems.
2. Research should inform the development and implementa-
tion of education for supervisors, managers, occupational
health practitioners, and human resource professionals about
legal issues protecting employees with health problems such as
cancer and include best practices for managing health issues in
the workplace.
3. Research is needed to develop tools and approaches that will
improve patient–employer communication; help employers
translate information about an employee’s limitations into
accommodations, plan for job retraining, and other assistance;
and evaluate those interventions on an ongoing basis.
4. Research should inform the development and implementa-
tion of programs and policies to address the unique needs of
small-scale employers and employees who do not typically
have access to current programs and policies.
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individuals at work would provide valuable context for
employment-focused interventions.
Gap 2: Employers’ needs for managing cancer survivors in
the workplace are not well documented.
Cancer is an umbrella term that encompasses diverse diag-
noses, treatments, symptomatology, and prognoses. Given the
limited communication between providers and employers,
patients are typically responsible for translating complex medi-
cal information for their supervisor or manager. This informa-
tion may include how long and to what extent cancer will affect
the essential functions of their job as well as how specific
accommodations could help them remain productive during
and following cancer treatment. Supervisors and managers are
instrumental in implementing an organization’s policies and
programs and are typically the first point of contact for employ-
ees with cancer or another health problem (62). However, indi-
vidual supervisors and managers as well as human resources
and occupational health staff may vary in their level of under-
standing and capacity to accommodate an employee’s needs, a
problem not unique to cancer. They may also overestimate the
negative impact of cancer on a person’s ability to work (63).
Future research should inform the development and implemen-
tation of evidence-based programs for supervisors, managers,
occupational health practitioners, and human resource profes-
sionals that include education about legal protections afforded
to employees with cancer as well as strategies to prevent work-
place discrimination and implement supportive accommoda-
tions. Additionally, research is needed to develop tools and
strategies that will improve patient–employer communication
and help employers translate information about a cancer survi-
vor’s limitations into accommodations such as gradual return
to work, flexible scheduling, modified performance expecta-
tions, retraining, and physical changes to the workplace (49).
The importance of paid sick leave has also been repeatedly
documented (64,65). Future research should identify the specific
accommodations that are most helpful under different circum-
stances and inform their implementation and evaluation.
Additionally, research is needed to inform reasonable accom-
modations for small-scale employers and across different work
environments. This research can build on existing findings
about employer needs, patient –employer communication, and
best practices for managing health issues in the workplace in
other disease areas to develop cancer-specific guidance (66,67).
Gap 3: Worksite wellness programs and policies are not uni-
versally available.
A robust evidence base is needed to inform the development
of workplace wellness programs and policies and employer ben-
efit that are tailored to different types of employers. For exam-
ple, 200 private, nonprofit and government employers have
earned Cancer CEO Gold Standard accreditation in recognition of
the provision of programs to their employees that include high-
quality care and survivorship (68). Select employers have also
contracted with third-party programs, such as the Johns Hopkins
Managing Cancer at Work program, to support their employees
with cancer (69). Several evidence-based toolkits, such as the
Workplace Transitions for people touched by cancer toolkit, have
been developed to help employers manage employees with can-
cer (70). Many employers, particularly large-scale employers,
have also implemented evidence-based policies and programs to
support employee health more generally (71). Future research
should identify the models of workplace wellness programs that
are available across different industries and assess the factors
driving employers’ interest in supporting these programs. In
particular, research is needed to inform the development of
resources that are tailored to the unique needs of small-scale
employers and employees who do not typically have access to
many of the resources described previously, such as workers
employed in low-skilled occupations, seasonal and part-time
workers, and temporary or contract workers. Finally, dissemina-
tion and implementation research and evaluation studies are
needed to understand how best to expand and integrate available
evidence-based interventions, programs, and policies into every-
day operations in a larger number of employment settings.
Cross-Cutting Recommendations (Box 4)
In addition to the recommendations presented above for im-
proving research and intervention at the patient, provider/
healthcare system, and employer levels, the meeting also
highlighted additional cross-cutting recommendations to ad-
vance research that addresses work outcomes after a cancer
diagnosis.
Recommendation 1. Develop enhanced partnerships and
stakeholder engagement to tackle the recommendations out-
lined in this report.
A coordinated approach to addressing cancer-related work
limitations across multiple sectors requires enhanced partner-
ships and stakeholder engagement. These engaged partner-
ships will ensure that interventions, programs, and policies for
mitigating the impact of cancer on employment are based on an
understanding of the specific problems and challenges encoun-
tered by employers, providers, and patients. Meeting partici-
pants suggested the creation of a cancer and work network as
one strategy for supporting enhanced partnerships and stake-
holder engagement. A formal cancer and work network could
facilitate collaboration among a cadre of researchers, practi-
tioners, employers and representatives from employer groups,
community organizations, and patient advocates. Such a net-
work could also foster information sharing and the dissemina-
tion of best practices for optimizing cancer-related employment
outcomes as well as provide central coordination for the activi-
ties outlined in this report.
Recommendation 2. Identify and develop standardized metrics
of work outcomes.
To build the evidence base for optimizing work outcomes af-
ter cancer, it is essential to identify and develop standardized
measures of employment outcomes. A set of standardized
measures would drive consistency in research and foster re-
search syntheses and meta-analyses, which are important for
informing policy. Standardized measures could support
employment-focused research as well as the integration of em-
ployment outcomes into behavioral, psychosocial, and clinical
research. Brief validated screening tools to capture information
about employment status and work-relevant limitations could
also inform care coordination and treatment decisions.
Furthermore, capturing and storing data on employment out-
comes in the EHR, in a retrievable way, would support the gen-
eration of an evidence base about the impact of specific
treatment regimens on cancer survivors’ employment out-
comes as well as develop the basis for evaluating how aspects
of clinical care impact employment.
Recommendation 3. Leverage implementation science to en-
sure that evidence-based, employment-focused interventions
are developed, evaluated, implemented, and sustained in real-
world healthcare delivery and employer-based settings.
Implementation science offers guidance for how to develop
and test employment-focused interventions to increase the
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likelihood of their subsequent adoption and appropriate use in
real-world healthcare delivery and employer settings (72).
Employment interventions should be conceptualized and devel-
oped with input from multistakeholder groups, including patients,
caregivers, providers, managers, employer groups, community
organizations, and payers. Multistakeholder input can ensure that
interventions reflect the considerations and priorities of relevant
groups, which is particularly important for the complex nature of
cancer-related employment outcomes (73). Additionally, interven-
tions should be designed with practicality in mind; interventions
that are too costly, labor intensive, cumbersome, and unappealing
are less likely to be adopted in real-world settings, even if they are
effective in research studies. Studies to evaluate interventions
should be designed to resemble real-world settings as much as
possible; pragmatic trials may be particularly appropriate for such
evaluations (74,75). Additionally publishing process evaluations
and data on intervention feasibility can help build the evidence
base to inform future intervention development and tailoring (76).
Research is also needed to identify effective strategies for in-
tegrating employment-focused interventions into routine set-
tings after an evidence base has been established. Strategies
may include traditional dissemination outlets, such as publica-
tions and use of social media to target end-users, but will likely
require more intensive efforts to reach full integration into
healthcare delivery and employer-based settings (77).
Summary
Over the past 25 years, a growing number of studies have docu-
mented the scope and severity of cancer-related work limitations.
However, many unanswered questions remain about the trajec-
tory and long-term impact of cancer on employment as well as
effective strategies for improving work outcomes. For people di-
agnosed with cancer, the ability to work is central to their quality
of life and is associated with multifaceted psychological, social,
and economic benefits. Thus, cancer survivors’ concerns about
work limitations and goals related to work should be addressed
throughout the course of care. The research agenda outlined in
this report is intended to drive multilevel solutions, at the level of
patients, providers, and employers, to optimizing work outcomes
for people who are diagnosed with cancer.
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